Dick Cheney
This article was originally published in The Gray Sheet
Executive Summary
Republican vice presidential nominee is treated with Guidant's MultiLink Tetra coronary stent Nov. 22 at the George Washington University Hospital in Washington, D.C., according to company officials. The fourth-generation stent received PMA supplement approval Oct. 3 (1"The Gray Sheet" Oct. 9, 2000, p. 16)
You may also be interested in...
Guidant Tetra Stent Approval Opens Opportunity To Recoup Lost Market Share
Guidant is looking to its Multi-Link Tetra fourth-generation coronary stent platform to recoup a recent loss in U.S. stent market share, following a drop-off in demand for its Tri-Star stent.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.